Deal Announcements

Apellis Pharma Adds Venture Capital Investment

Tuesday, June 21, 2011 5:39:00 AM PDT | VentureDeal Staff

Louisville, Kentucky  --  Apellis Pharmaceuticals has received $1.28 million in new venture capital financing, according to an SEC regulatory filing.

Apellis is in early-stage drug company focused on peptide drugs in the immunology space.

Investors in the financing were not disclosed. The company is still seeking an additional $1.25 million in financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1